Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Sharecare (SHCR) Stock Forecast & Price Target

Sharecare logo
Get the Latest News and Ratings for SHCR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sharecare and its competitors.

Sign Up

SHCR Analyst Ratings Over Time

TypeCurrent Forecast
12/4/23 to 12/3/24
1 Month Ago
11/4/23 to 11/3/24
3 Months Ago
9/5/23 to 9/4/24
1 Year Ago
12/4/22 to 12/4/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$1.43$1.43$1.43$2.00
Forecasted UpsideN/AN/A2.88% Upside115.05% Upside
Consensus Rating
Hold
Hold
Hold
Hold

SHCR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SHCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sharecare Stock vs. The Competition

TypeSharecareMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.81
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted UpsideN/A25,916.81% Upside7.05% Upside
News Sentiment Rating
Neutral News

See Recent SHCR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/24/2024Morgan Stanley
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$1.00 ➝ $1.43+4.38%
6/21/2024Canaccord Genuity Group
4 of 5 stars
R. Close
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/1/2024BTIG Research
2 of 5 stars
 DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:23 PM ET.


SHCR Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Sharecare is $1.43, with a high forecast of $1.43 and a low forecast of $1.43.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sharecare in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SHCR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SHCR, but not buy additional shares or sell existing shares.

Analysts like Sharecare less than other "medical" companies. The consensus rating for Sharecare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SHCR compares to other companies.


This page (NASDAQ:SHCR) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners